436
R. Mankamna Kumari et al.
Chen F, Zhang Z-R, Yuan F, Qin X, Wang M, Huang Y (2008a) In vitro and in vivo study of
N-trimethyl chitosan nanoparticles for oral protein delivery. Int J Pharm 349:226–233
Chen J et al (2008b) Galactose-poly (ethylene glycol)-polyethylenimine for improved lung gene
transfer. Biochem Biophys Res Commun 375:378–383
Christian DA, Cai S, Garbuzenko OB, Harada T, Zajac AL, Minko T, Discher DE (2009) Flexible
filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage
window for sustained tumor shrinkage. Mol Pharm 6:1343–1352
Chumakova OV et al (2008) Composition of PLGA and PEI/DNA nanoparticles improves
ultrasound-mediated gene delivery in solid tumors in vivo. Cancer Lett 261:215–225
Crucho CI, Barros MT (2015) Formulation of functionalized PLGA polymeric nanoparticles for
targeted drug delivery. Polymer 68:41–46
Dalhaimer P, Bates FS, Discher DE (2003) Single molecule visualization of stable, stiffness-tunable,
flow-conforming worm micelles. Macromolecules 36:6873–6877
Dalhaimer P, Bermudez H, Discher D (2004) Biopolymer mimicry with polymeric worm-like
micelles: MW-scaled flexibility, locked-in curvature, and coexisting microphases. In: Abstracts
of papers of the American chemical society, 2004. Amer chemical soc 1155 16th St, NW,
Washington, DC 20036 USA, pp U543–U544
Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V (2012) PLGA-based nanoparticles:
an overview of biomedical applications. J Control Release 161:505–522
De La Zerda A et al (2008) Carbon nanotubes as photoacoustic molecular imaging agents in living
mice. Nat Nanotechnol 3:557
Decuzzi P, Godin B, Tanaka T, Lee S-Y, Chiappini C, Liu X, Ferrari M (2010) Size and shape effects
in the biodistribution of intravascularly injected particles. J Control Release 141:320–327
Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL (1997) The mechanism of uptake of
biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 14:1568–1573
Dobrovolskaia MA, McNeil SE (2007) Immunological properties of engineered nanomaterials. Nat
Nanotechnol 2:469
Dube A, Reynolds JL, Law W-C, Maponga CC, Prasad PN, Morse GD (2014) Multimodal nanoparticles that provide immunomodulation and intracellular drug delivery for infectious diseases.
Nanomed Nanotechnol Biol Med 10:831–838
Elias DR, Poloukhtine A, Popik V, Tsourkas A (2013) Effect of ligand density, receptor density,
and nanoparticle size on cell targeting. Nanomedicine: Nanotechnol Biol Med 9:194–201
Elsabahy M, Nazarali A, Foldvari M (2011) Non-viral nucleic acid delivery: key challenges and
future directions. Curr Drug Deliv 8:235–244
Essex S, Navarro G, Sabhachandani P, Chordia A, Trivedi M, Movassaghian S, Torchilin VP (2015)
Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrugresistant tumors. Gene Ther 22:257
Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J (2013) The big
picture on small medicine: the state of nanomedicine products approved for use or in clinical
trials. Nanomedicine: Nanotechnol Biol Med 9:1
Fan S et al (2018) Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for
potential use in Alzheimer’s disease. Drug Deliv 25:1091–1102
Farlow MR (2001) Pharmacokinetic profiles of current therapies for Alzheimer’s disease: implications for switching to galantamine. Clin Ther 23:A13–A24
Fischer HC, Chan WC (2007) Nanotoxicity: the growing need for in vivo study. Curr Opin
Biotechnol 18:565–571
Gao Y, Liu X-L, Li X-R (2011) Research progress on siRNA delivery with nonviral carriers. Int J
Nanomed 6:1017
Gazori T, Khoshayand MR, Azizi E, Yazdizade P, Nomani A, Haririan I (2009) Evaluation of Alginate/Chitosan nanoparticles as antisense delivery vector: formulation, optimization and in vitro
characterization. Carbohydr Polym 77:599–606
Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, Minko T, Discher DE (2007) Shape effects of
filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2:249
R. Mankamna Kumari et al.
Chen F, Zhang Z-R, Yuan F, Qin X, Wang M, Huang Y (2008a) In vitro and in vivo study of
N-trimethyl chitosan nanoparticles for oral protein delivery. Int J Pharm 349:226–233
Chen J et al (2008b) Galactose-poly (ethylene glycol)-polyethylenimine for improved lung gene
transfer. Biochem Biophys Res Commun 375:378–383
Christian DA, Cai S, Garbuzenko OB, Harada T, Zajac AL, Minko T, Discher DE (2009) Flexible
filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage
window for sustained tumor shrinkage. Mol Pharm 6:1343–1352
Chumakova OV et al (2008) Composition of PLGA and PEI/DNA nanoparticles improves
ultrasound-mediated gene delivery in solid tumors in vivo. Cancer Lett 261:215–225
Crucho CI, Barros MT (2015) Formulation of functionalized PLGA polymeric nanoparticles for
targeted drug delivery. Polymer 68:41–46
Dalhaimer P, Bates FS, Discher DE (2003) Single molecule visualization of stable, stiffness-tunable,
flow-conforming worm micelles. Macromolecules 36:6873–6877
Dalhaimer P, Bermudez H, Discher D (2004) Biopolymer mimicry with polymeric worm-like
micelles: MW-scaled flexibility, locked-in curvature, and coexisting microphases. In: Abstracts
of papers of the American chemical society, 2004. Amer chemical soc 1155 16th St, NW,
Washington, DC 20036 USA, pp U543–U544
Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V (2012) PLGA-based nanoparticles:
an overview of biomedical applications. J Control Release 161:505–522
De La Zerda A et al (2008) Carbon nanotubes as photoacoustic molecular imaging agents in living
mice. Nat Nanotechnol 3:557
Decuzzi P, Godin B, Tanaka T, Lee S-Y, Chiappini C, Liu X, Ferrari M (2010) Size and shape effects
in the biodistribution of intravascularly injected particles. J Control Release 141:320–327
Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL (1997) The mechanism of uptake of
biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 14:1568–1573
Dobrovolskaia MA, McNeil SE (2007) Immunological properties of engineered nanomaterials. Nat
Nanotechnol 2:469
Dube A, Reynolds JL, Law W-C, Maponga CC, Prasad PN, Morse GD (2014) Multimodal nanoparticles that provide immunomodulation and intracellular drug delivery for infectious diseases.
Nanomed Nanotechnol Biol Med 10:831–838
Elias DR, Poloukhtine A, Popik V, Tsourkas A (2013) Effect of ligand density, receptor density,
and nanoparticle size on cell targeting. Nanomedicine: Nanotechnol Biol Med 9:194–201
Elsabahy M, Nazarali A, Foldvari M (2011) Non-viral nucleic acid delivery: key challenges and
future directions. Curr Drug Deliv 8:235–244
Essex S, Navarro G, Sabhachandani P, Chordia A, Trivedi M, Movassaghian S, Torchilin VP (2015)
Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrugresistant tumors. Gene Ther 22:257
Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J (2013) The big
picture on small medicine: the state of nanomedicine products approved for use or in clinical
trials. Nanomedicine: Nanotechnol Biol Med 9:1
Fan S et al (2018) Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for
potential use in Alzheimer’s disease. Drug Deliv 25:1091–1102
Farlow MR (2001) Pharmacokinetic profiles of current therapies for Alzheimer’s disease: implications for switching to galantamine. Clin Ther 23:A13–A24
Fischer HC, Chan WC (2007) Nanotoxicity: the growing need for in vivo study. Curr Opin
Biotechnol 18:565–571
Gao Y, Liu X-L, Li X-R (2011) Research progress on siRNA delivery with nonviral carriers. Int J
Nanomed 6:1017
Gazori T, Khoshayand MR, Azizi E, Yazdizade P, Nomani A, Haririan I (2009) Evaluation of Alginate/Chitosan nanoparticles as antisense delivery vector: formulation, optimization and in vitro
characterization. Carbohydr Polym 77:599–606
Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, Minko T, Discher DE (2007) Shape effects of
filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2:249